Compounds > thenoyltrifluoroacetone
Page last updated: 2024-08-16

thenoyltrifluoroacetone and rifampin

thenoyltrifluoroacetone has been researched along with rifampin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chegaev, K; Chung, MC; de Souza, PC; Dos Santos, JL; Fernandes, GFDS; Fruttero, R; Guglielmo, S; Lazzarato, L; Marino, LB; Pavan, FR1
Beuerman, RW; Cao, D; Corkran, HM; Dick, T; Koh, JJ; Lakshminarayanan, R; Lim, F; Lin, S; Liu, S; Mukherjee, D; Stocker, BL; Tan, DTH; Tan, DZ; Tan, JK; Timmer, MSM; Zou, H1

Other Studies

3 other study(ies) available for thenoyltrifluoroacetone and rifampin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
    European journal of medicinal chemistry, 2016, Nov-10, Volume: 123

    Topics: Antitubercular Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Design; Humans; Mycobacterium tuberculosis; Oxadiazoles

2016
Amphiphilic xanthones as a potent chemical entity of anti-mycobacterial agents with membrane-targeting properties.
    European journal of medicinal chemistry, 2016, Nov-10, Volume: 123

    Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Biological Availability; Cell Membrane; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Hydrophobic and Hydrophilic Interactions; Kinetics; Mycobacterium tuberculosis; Rats; Xanthones

2016